日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors

IPH5201,一种抗CD39单克隆抗体,可作为单药疗法或与度伐利尤单抗联合用于治疗晚期实体瘤。

Powderly, John; Imbimbo, Martina; Italiano, Antoine; Martin-Romano, Patricia; McKean, Meredith; Macarulla, Teresa; Castañón Alvarez, Eduardo; Carneiro, Benedito A; Mager, Raymond; Barnhart, Vicky; Eck, Steven; Murtomaki, Elina; Loembé, Arsène-Bienvenu; He, Yun; Cooper, Zachary A; Tu, Eric; Fan, Chunling; Boyer Chamard, Agnes; Paturel, Carine; Fraenkel, Paula G; Hollebecque, Antoine

Simultaneous signal optimization of refraction and attenuation in x-ray grating interferometry: A case study for breast imaging

X射线光栅干涉测量中折射和衰减的同时信号优化:以乳腺成像为例

Pereira, Alexandre; Rawlik, Michał; Spindler, Simon; Kaser, Stefanie; Etter, Dominik; Iori, Gianluca; Stauber, Martin; Romano, Lucia; Stampanoni, Marco

Critical Consciousness in Sport Scale (CCSS): development and initial psychometrics properties

运动批判意识量表(CCSS):开发及初步心理测量学特性

Peixoto, Evandro Morais; Camiré, Martin; Romano, Amanda Rizzieri

Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors

转化生长因子-β (TGFβ) 抑制剂 SAR439459 作为单一疗法和与 cemiplimab 联合治疗晚期实体肿瘤患者的 I 期临床研究的生物标志物和药效学活性

Debbie Robbrecht, Jean-Jacques Grob, Oliver Bechter, Matteo Simonelli, Bernard Doger, Ivan Borbath, Marcus O Butler, Tina Cheng, Patricia Martin Romano, Elvire Pons-Tostivint, Massimo Di Nicola, Giuseppe Curigliano, Min-Hee Ryu, Alejo Rodriguez-Vida, Dirk Schadendorf, Elena Garralda, Giovanni Abbade

Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits

血液分子表型的遗传分析揭示了影响复杂性状的调控网络中的共同特征

Brown, Andrew A; Fernandez-Tajes, Juan J; Hong, Mun-Gwan; Brorsson, Caroline A; Koivula, Robert W; Davtian, David; Dupuis, Théo; Sartori, Ambra; Michalettou, Theodora-Dafni; Forgie, Ian M; Adam, Jonathan; Allin, Kristine H; Caiazzo, Robert; Cederberg, Henna; De Masi, Federico; Elders, Petra J M; Giordano, Giuseppe N; Haid, Mark; Hansen, Torben; Hansen, Tue H; Hattersley, Andrew T; Heggie, Alison J; Howald, Cédric; Jones, Angus G; Kokkola, Tarja; Laakso, Markku; Mahajan, Anubha; Mari, Andrea; McDonald, Timothy J; McEvoy, Donna; Mourby, Miranda; Musholt, Petra B; Nilsson, Birgitte; Pattou, Francois; Penet, Deborah; Raverdy, Violeta; Ridderstråle, Martin; Romano, Luciana; Rutters, Femke; Sharma, Sapna; Teare, Harriet; 't Hart, Leen; Tsirigos, Konstantinos D; Vangipurapu, Jagadish; Vestergaard, Henrik; Brunak, Søren; Franks, Paul W; Frost, Gary; Grallert, Harald; Jablonka, Bernd; McCarthy, Mark I; Pavo, Imre; Pedersen, Oluf; Ruetten, Hartmut; Walker, Mark; Adamski, Jerzy; Schwenk, Jochen M; Pearson, Ewan R; Dermitzakis, Emmanouil T; Viñuela, Ana

Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

作者更正:分子肿瘤委员会门户网站支持精准肿瘤学的临床决策和自动化报告。

Tamborero, David; Dienstmann, Rodrigo; Rachid, Maan Haj; Boekel, Jorrit; Lopez-Fernandez, Adria; Jonsson, Markus; Razzak, Ali; Braña, Irene; De Petris, Luigi; Yachnin, Jeffrey; Baird, Richard D; Loriot, Yohann; Massard, Christophe; Martin-Romano, Patricia; Opdam, Frans; Schlenk, Richard F; Vernieri, Claudio; Masucci, Michele; Villalobos, Xenia; Chavarria, Elena; Balmaña, Judith; Apolone, Giovanni; Caldas, Carlos; Bergh, Jonas; Ernberg, Ingemar; Fröhling, Stefan; Garralda, Elena; Karlsson, Claes; Tabernero, Josep; Voest, Emile; Rodon, Jordi; Lehtiö, Janne

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

分子肿瘤委员会门户网站为精准肿瘤学的临床决策和自动化报告提供支持。

Tamborero, David; Dienstmann, Rodrigo; Rachid, Maan Haj; Boekel, Jorrit; Lopez-Fernandez, Adria; Jonsson, Markus; Razzak, Ali; Braña, Irene; De Petris, Luigi; Yachnin, Jeffrey; Baird, Richard D; Loriot, Yohann; Massard, Christophe; Martin-Romano, Patricia; Opdam, Frans; Schlenk, Richard F; Vernieri, Claudio; Masucci, Michele; Villalobos, Xenia; Chavarria, Elena; Balmaña, Judith; Apolone, Giovanni; Caldas, Carlos; Bergh, Jonas; Ernberg, Ingemar; Fröhling, Stefan; Garralda, Elena; Karlsson, Claes; Tabernero, Josep; Voest, Emile; Rodon, Jordi; Lehtiö, Janne

Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers

尼达尼布联合帕博利珠单抗治疗晚期癌症患者的安全性、推荐剂量、疗效及免疫相关性

Capucine Baldini #, Francois-Xavier Danlos #, Andreea Varga, Matthieu Texier, Heloise Halse, Severine Mouraud, Lydie Cassard, Stéphane Champiat, Nicolas Signolle, Perrine Vuagnat, Patricia Martin-Romano, Jean-Marie Michot, Rastislav Bahleda, Anas Gazzah, Lisa Boselli, Delphine Bredel, Jonathan Grive

Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation

JNJ-74699157治疗携带KRAS G12C突变的晚期实体瘤患者的I期研究

Wang, Judy; Martin-Romano, Patricia; Cassier, Philippe; Johnson, Melissa; Haura, Eric; Lenox, Laurie; Guo, Yue; Bandyopadhyay, Nibedita; Russell, Michael; Shearin, Elizabeth; Lauring, Josh; Dahan, Laetitia

Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic

在新冠肺炎疫情第一波期间,法国一家医院持续开展癌症临床试验活动

Bayle, Arnaud; Baldini, Capucine; Martin-Romano, Patricia; Michot, Jean-Marie; Champiat, Stéphane; Bahleda, Rastilav; Gazzah, Anas; Marabelle, Aurélien; Verlingue, Loic; Geraud, Arthur; Morel, Daphné; Michiels, Stefan; Hollebecque, Antoine; Albiges, Laurence; Besse, Benjamin; Soria, Jean-Charles; Massard, Christophe; Barlesi, Fabrice; Postel-Vinay, Sophie